Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sarpogrelate

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 125926-17-2, Sarpogrelate [inn], Sarpogrelate (inn), 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid, 19p708e787, Unii-19p708e787
    Molecular Formula
    C24H31NO6
    Molecular Weight
    429.5  g/mol
    InChI Key
    FFYNAVGJSYHHFO-UHFFFAOYSA-N
    FDA UNII
    19P708E787
    Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid
    2.1.2 InChI
    InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)
    2.1.3 InChI Key
    FFYNAVGJSYHHFO-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    19P708E787
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl Hydrogensuccinate Hydrochloride

    2. Mci 9042

    3. Mci-9042

    4. Mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate Hydrochloride

    2.3.2 Depositor-Supplied Synonyms

    1. 125926-17-2

    2. Sarpogrelate [inn]

    3. Sarpogrelate (inn)

    4. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid

    5. 19p708e787

    6. Unii-19p708e787

    7. Ncgc00167489-01

    8. Ncgc00167489-03

    9. Schembl49197

    10. Gtpl210

    11. Chembl52939

    12. Sarpogrelate [who-dd]

    13. Dtxsid7048328

    14. Chebi:135697

    15. Bcp08179

    16. Bdbm50093789

    17. Stk631325

    18. Akos005563803

    19. Db12163

    20. Ncgc00167489-02

    21. 4-{[1-(dimethylamino)-3-{2-[2-(3-methoxyphenyl)ethyl]phenoxy}propan-2-yl]oxy}-4-oxobutanoic Acid

    22. Hy-10563

    23. Cs-0002654

    24. Ft-0712621

    25. Ls-187,118

    26. D08508

    27. Q44931

    28. 159s512

    29. L000858

    30. Sr-01000883998

    31. J-513134

    32. Sr-01000883998-1

    33. (+-)-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate

    34. (- )-2-(dimethylamino)-1-((o-(m-methoxyphenethyl)phenoxy)methyl)ethyl Hydrogen Succinate.

    35. 4-(1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yloxy)-4-oxobutanoic Acid

    36. 4-((1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoic Acid

    37. 4-(1-(2-(3-methoxyphenethyl)phenoxy)-3-(dimethylamino)propan-2-yloxy)-4-oxobutanoic Acid Sarpogrelate

    38. 4-[1-dimethylamino-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid

    39. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester

    40. Butanedioic Acid,1-[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester

    41. Succinic Acid Mono-(2-dimethylamino-1-{2-[2-(3-methoxy-phenyl)-ethyl]-phenoxymethyl}-ethyl) Ester; Hydrochloride

    2.4 Create Date
    2005-03-25
    3 Chemical and Physical Properties
    Molecular Weight 429.5 g/mol
    Molecular Formula C24H31NO6
    XLogP31.2
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count14
    Exact Mass429.21513771 g/mol
    Monoisotopic Mass429.21513771 g/mol
    Topological Polar Surface Area85.3 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity540
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Fibrinolytic Agents

    Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)

    Serotonin Antagonists

    Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)

    Platelet Aggregation Inhibitors

    Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)